Gainers

• Profusa (NASDAQ:PFSA) shares rose 148.0% to $1.88 during Monday's regular session. The market value of their outstanding shares is at $1.0 million.
• IO Biotech (NASDAQ:IOBT) shares rose 53.25% to $0.05. The market value of their outstanding shares is at $2.3 million.
• PRF Technologies (NASDAQ:PRFX) shares increased by 32.38% to $2.78. The market value of their outstanding shares is at $1.7 million.
• Soleno Therapeutics (NASDAQ:SLNO) stock rose 32.37% to $52.27. The market value of their outstanding shares is at $2.1 billion.
• Estrella Immunopharma (NASDAQ:ESLA) shares increased by 27.61% to $1.34. The market value of their outstanding shares is at $44.7 million.
• ABVC BioPharma (NASDAQ:ABVC) stock increased by 25.68% to $1.37. The company's market cap stands at $27.7 million.

Losers

• Akari Therapeutics (NASDAQ:AKTX) shares fell 23.9% to $3.4 during Monday's regular session. The company's market cap stands at $159.7 million.
• Viridian Therapeutics (NASDAQ:VRDN) shares decreased by 22.64% to $14.57. The market value of their outstanding shares is at $1.7 billion.
• Aditxt (NASDAQ:ADTX) shares declined by 22.27% to $0.62.
• Lunai Bioworks (NASDAQ:LNAI) shares declined by 19.92% to $0.3. The market value of their outstanding shares is at $9.0 million.
• Cyclerion Therapeutics (NASDAQ:CYCN) stock fell 19.68% to $4.94. The market value of their outstanding shares is at $23.4 million.
• Polaryx Therapeutics (NASDAQ:PLYX) stock declined by 19.61% to $5.74. The market value of their outstanding shares is at $338.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.